within Pharmacolibrary.Drugs.C_CardiovascularSystem.C08C_SelectiveCalciumChannelBlockersWithMainlyVascularEffects.C08CA06_Nimodipine;
model Nimodipine 
   extends Pharmacolibrary.Drugs.ATC.C.C08CA06;

  annotation(Documentation(
    info ="<html><body><p>Nimodipine is a dihydropyridine calcium channel blocker used primarily to reduce the incidence and severity of neurological deficits arising from cerebral vasospasm following subarachnoid hemorrhage. Approved and used today mainly for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Moreno, LCGEAI, et al., &amp; Irache, JM (2018). Pegylated nanoparticles for the oral delivery of nimodipine: Pharmacokinetics and effect on the anxiety and cognition in mice. <i>International journal of pharmaceutics</i> 543(1-2) 245–256. DOI:<a href=&quot;https://doi.org/10.1016/j.ijpharm.2018.03.048&quot;>10.1016/j.ijpharm.2018.03.048</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29604372/&quot;>https://pubmed.ncbi.nlm.nih.gov/29604372</a></p></li><li><p>Macdonald, RL, et al., &amp; Aldrich, F (2021). Nimodipine pharmacokinetics after intraventricular injection of sustained-release nimodipine for subarachnoid hemorrhage. <i>Journal of neurosurgery</i> 134(1) 95–101. DOI:<a href=&quot;https://doi.org/10.3171/2019.9.JNS191366&quot;>10.3171/2019.9.JNS191366</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31812149/&quot;>https://pubmed.ncbi.nlm.nih.gov/31812149</a></p></li><li><p>Liu, W, et al., &amp; Yang, M (2016). Effect of age on the pharmacokinetics of polymorphic nimodipine in rats after oral administration. <i>Acta pharmaceutica Sinica. B</i> 6(5) 468–474. DOI:<a href=&quot;https://doi.org/10.1016/j.apsb.2016.07.010&quot;>10.1016/j.apsb.2016.07.010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27709016/&quot;>https://pubmed.ncbi.nlm.nih.gov/27709016</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Nimodipine;
